Ro48-8684 is a water-soluble benzodiazepine derivative developed by Hoffman-LaRoche in the 1990s, which was designed along with Ro48-6791 as an improved replacement for midazolam, but ultimately proved to have little advantages over the parent drug and has not been introduced into clinical practice.[1][2]
Identifiers | |
---|---|
| |
PubChem CID |
|
ChemSpider |
|
Chemical and physical data | |
Formula | C22H26FN5O2 |
Molar mass | 411.472 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(verify) |